HP and Alzheimer disease: Currently it is unclear whether the changes observed in the Hp-enriched AD plasma are simply readouts of protein level changes in the AD brain reflected in the plasma or evidence that AD pathophysiology directly impacts peripheral organ function in a way that drives biomarkers changes, which can be observed in plasma.